The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators
Open accessAbstract
Atherosclerosis is now recognized as an inflammatory disease involving the vascular wall. Recent results indicate that acute inflammation does not simply passively resolve as previously assumed but is actively terminated by a homeostatic process that is governed by specific lipid‐derived mediators initiated by lipoxygenases. Experiments with animals and humans support a proinflammatory role for the 5‐lipoxygenase system. In contrast, results from animal experiments showa range of responses with the 12/15‐lipoxygenase pathways in atherosclerosis. To date, the only two clinical epidemiology human studies both support an antiatherogenic role for 12/15‐lipoxygenase downstream actions. We tested the hypothesis that atherosclerosis results from a failure in the resolution of local inflammation by analyzing apolipoprotein E‐deficient mice with 1 ) global leukocyte 12/15‐lipoxygenase deficiency, 2 ) normal enzyme expression, or 3 ) macrophage‐specific 12/15‐lipoxygenase overexpression. Results from these indicate that 12/15‐lipoxy‐genase expression protects mice against atherosclerosis via its role in the local biosynthesis of lipid mediators, including lipoxin A 4 , resolvin D1, and protectin D1. These mediators exert potent agonist actions on macrophages and vascular endothelial cells that can control the magnitude of the local inflammatory response. Taken together, these findings suggest that a failure of local endogenous resolution mechanisms may underlie the unremitting inflammation that fuels atherosclerosis.—Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N. Chan, L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595–3606 (2008)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many chronic inflammatory diseases, including advanced atherosclerosis, are characterized by an imbalance between pro-resolving and pro-inflammatory mediators, such as leukotrienes, leading to defective resolution of inflammation, tissue injury and damage-associated molecular pattern (DAMP)-mediated inflammation31–33.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,796
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. O. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,839
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Self-citationBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationStary, H. C., Chandler, A. B., Glagov, S. K., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Circulation · doi:10.1161/01.cir.89.5.2462 · Cited by 1,313
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,219
Self-citation
Flagged first, then by citations
1 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 415
The Counter-Regulation of Atherogenesis: a Role for Interleukin-33
Kunes, P., Holubcová, Z., Koláčková, M., & Krejsek, J. (2010) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2016.71 · Cited by 11
Acute Coronary Syndrome May be Associated with Decreased Resolvin D1-to-Leukotriene B4 Ratio
Sun, C., Zheng, W., Liang, L., Zhang, Z., Liu, Z., Sun, W., Zhou, J., Qiao, W., Xie, Q., & Tang, R. (2023) · International Heart Journal · doi:10.1536/ihj.22-361 · Cited by 11
Najeeb, A. (2011) · Frontiers in bioscience · doi:10.2741/3978 · Cited by 11
Microinflammation Factors in the Common Diseases of the Heart and Kidneys
Tasić, D., Radenković, S., Kocic, G. M., Ilic, M. D., & Ignjatović, A. (2015) · Disease Markers · doi:10.1155/2015/470589 · Cited by 10
Sroczyńska, K., Totoń‐Żurańska, J., Czepiel, J., Zając, A., Jurczyszyn, A. J., Wołkow, P. P., Librowski, T., & Gdula‐Argasińska, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120345 · Cited by 10
Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque
Thorp, E. B. (2016) · Circulation Research · doi:10.1161/circresaha.116.309794 · Cited by 10
JAKinibs prevent persistent, IFNγ-autonomous endothelial cell inflammation and immunogenicity
Valenzuela, N. M. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00298.2022 · Cited by 10
Wei, C., Zhu, F., Yu, J., Gao, F., Yuan, Y., Zhang, Y., Liu, X., Chu, S., Cui, D., Fan, H., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14247 · Cited by 8
Zhao, R.-J., Pan, Z.-Y., Long, C.-L., Cui, W., Zhang, Y., & Wang, H. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.029 · Cited by 9
Pelosi, G., Rocchiccioli, S., Cecchettini, A., Viglione, F., Puntoni, M., Parodi, O., Capobianco, E., & Trivella, M. G. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00070 · Cited by 9
Hu, F., Feng, A.-P., Liu, X., Zhang, S., Xu, J., Wang, X., Zhong, X.-L., He, M. L., & Chen, H. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1448-8 · Cited by 9
Calderon Artero, P. (2011) · Journal of Glycomics & Lipidomics · doi:10.4172/2153-0637.1000104 · Cited by 8
Kwack, W.-G., Lee, Y.-J., Eo, E., Chung, J.-H., Lee, J., & Cho, Y. (2021) · Nutrients · doi:10.3390/nu13072258 · Cited by 8
Proresolving receptor tames inflammation in atherosclerosis
Mena, H. A., & Spite, M. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci155240 · Cited by 8
Chen, L., Tseng, H., Kuo, M., Chiu, C., Liao, S.-L., Su, K., Tsai, M., Hua, M., Lai, S., Yao, T., et al. (2017) · Allergy · doi:10.1111/all.13318 · Cited by 8
Zhang, Y., & Igwe, O. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.021 · Cited by 8
Tatsuno, I. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.971756 · Cited by 7
Potential of specialized pro-resolving lipid mediators against rheumatic diseases
Murakami, K. (2016) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.39.155 · Cited by 7
Resolvin D1 down-regulates CYP1A1 and PTGS2 gene in the HUVEC cells treated with benzo(a)pyrene
Gdula‐Argasińska, J., Czepiel, J., Totoń‐Żurańska, J., Jurczyszyn, A. J., Wołkow, P. P., Librowski, T., & Perucki, W. H. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.05.005 · Cited by 7
Rueda, F., Domingo, J. C., & Mach, N. (2011) · Revista Española de Nutrición Humana y Dietética · doi:10.1016/s2173-1292(11)70004-7 · Cited by 7
Urinary lipoxin A4 as a biomarker for systemic lupus erythematosus
Abdou, M. M. S., Effat, D., Mansour, L. A., Baky, N. A. E., & Salam, M. M. A. (2015) · Egyptian Rheumatology and Rehabilitation · doi:10.4103/1110-161x.157861 · Cited by 6
Heydeck, D., Ufer, C., Kakularam, K. R., Rothe, M., Liehr, T., Poulain, P., & Kühn, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054815 · Cited by 5
Zhang, Q., Du, G., Lu, T., Guo, X., & Wei, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166805 · Cited by 6
Tajbakhsh, A., Yousefi, F., Farahani, N., Savardashtaki, A., Reiner, Ž., Jamialahmadi, T., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230727100123 · Cited by 5
Oxylipins biosynthesis and the regulation of bovine postpartum inflammation
Gong, J. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106814 · Cited by 5
Kim, H. Y., Ju, H. K., Choi, J. H., Kang, Y. J., Park, S. Y., & Kim, H. S. (2015) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2015.45.2.138 · Cited by 5
Balogun, K. A., & Cheema, S. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_27 · Cited by 5
Shichiri, M., Ishida, N., Aoki, Y., Koike, T., & Hagihara, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.236 · Cited by 5
Protective effects of resolvin D1 in Pseudomonas aeruginosa keratitis
Wu, J., Gao, J., Yi, L., Gao, N., Wang, L., Zhu, J., Dai, C., Sun, L., Guo, H., Wu, X., et al. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.04.007 · Cited by 6
Gomma, A. E., Srour, T. M., & Abdal, A. E. M. (2020) · American Journal of Food Technology · doi:10.3923/ajft.2020.49.61 · Cited by 5
Lipid Signatures of Unstable Atheromas
Spite, M. R., & Serhan, C. N. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.960344 · Cited by 5
Self-citationRegidor, P., Mayr, M., Santos, F. G., Calvo, B. L., Gutiérrez, R., & Rizo, J. M. (2025) · Biomedicines · doi:10.3390/biomedicines13081832 · Cited by 4
The role of ALOX15 in inflammation-related diseases
Tang, R., Gong, C.-Y., Liu, Y., Zhong, H.-L., Wang, Y.-B., & Zhou, H.-Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790402 · Cited by 4
Çelik, Z., Özen, G., Sunar, S., Türkyılmaz, S., Türkyılmaz, G., Kavala, A. A., Teskìn, Ö., Doğan, B. S. U., & Topal, G. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106786 · Cited by 4
Lipoxins, Resolvins, and the Resolution of Inflammation
Recchiuti, A., Cianci, E., Simiele, F., & Romano, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27766-0_10 · Cited by 4
Fine-tuning inflammation-resolution programs
Fredman, G., Sadhu, S., & Rymut, N. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000351 · Cited by 4
Heydeck, D., Kakularam, K. R., Łabuz, D., Machelska, H., Rohwer, N., Weylandt, K. H., & Kühn, H. (2023) · Inflammation Research · doi:10.1007/s00011-023-01770-8 · Cited by 5
Wei, T., Zhou, R., Luo, T. F., Deng, Z., & Li, J. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-19715 · Cited by 4
Abumrad, N. A., Piomelli, D., Yurko‐Mauro, K., Merrill, A. H., Clandinin, M. T., & Serhan, C. N. (2012) · Advances in Nutrition · doi:10.3945/an.111.000802 · Cited by 4
Self-citationReisch, F., Schäfer, M., Łabuz, D., Machelska, H., Stehling, S., Püschel, G. P., Rothe, M., Heydeck, D., & Kühn, H. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00756-0 · Cited by 3
Nutrigenomics and Nutrigenetics
Corcuff, J., & Merched, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00003-0 · Cited by 3
Self-citationOxidized Lipoproteins as the Diagnostic Target for Cardiovascular Diseases
Sreeja, S., Manoharan, A., & Venkataraman, K. (2018) · Current Science · doi:10.18520/cs/v115/i7/1276-1286 · Cited by 2
Biologically Active Lipids in Vascular Biology
Upchurch, C. M., & Leitinger, N. (2019) · Learning materials in biosciences · doi:10.1007/978-3-030-12270-6_9 · Cited by 3
Systems medicine and periodontal diseases
Sima, C., & Dyke, T. E. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813762-8.00011-6 · Cited by 3
Relevance of DHA‐containing lysophospholipids
Lagarde, M., & Bernoud‐Hubac, N. (2012) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100391 · Cited by 4
The role of lipoxins in cardiometabolic physiology and disease
Börgeson, E. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000068 · Cited by 3
Omega-3 Polyunsaturated Fatty Acid and Coronary Atherosclerotic Plaques
Nakao, T., & Morita, H. (2017) · International Heart Journal · doi:10.1536/ihj.17-552 · Cited by 3
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_10 · Cited by 3
Gomaa, A., Srour, T. M., & Abdallah, A. A.-A. (2019) · Journal of the Advances in Agricultural Researches/Journal of the Advances in Agricultural Researches · doi:10.21608/jalexu.2019.163500 · Cited by 2
Regidor, P., Eiblwieser, J., Steeb, T., & Rizo, J. M. (2024) · F1000Research · doi:10.12688/f1000research.153569.3 · Cited by 2
Resolution to Inflammation: Its Role in Reducing Fibrosis and Tissue Repair
Meiliana, A., & Wijaya, A. (2023) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v15i2.2181 · Cited by 1
Coplanar PCB-induced inflammation and dietary interventions
Eske, K. (2013) · UKnowledge (University of Kentucky) · Cited by 2
Spinelli, S. L., Lannan, K. L., Loelius, S. G., & Phipps, R. P. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0034 · Cited by 2
A Novel Genus of Specialized Anti-Inflammatory and Pro-Resolution Lipid Mediators
Bannenberg, G. L., & Serhan, C. N. (2010) · Neuroimmune biology · doi:10.1016/s1567-7443(10)70009-0 · Cited by 2
Self-citationAnti-inflammatory and Atheroprotective Properties of Omega-3 Polyunsaturated Fatty Acids
Sorokin, A. V., Yang, Z. H., & Remaley, A. T. (2016) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000478 · Cited by 2
Dietary Intervention in Coronary Care Units and in Secondary Prevention
de Lorgeril, M., & Salen, P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-4927-2.00031-1 · Cited by 2
Gündem, E., Stehling, S., Borchert, A., & Kühn, H. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100768 · Cited by 1
Kwiatkowski, G., Czyżyńska-Cichoń, I., Gdula, A. M., Zakrzewska, A., Tyrankiewicz, U., Sitek, B., Jasztal, A., & Chłopicki, S. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134266 · Cited by 1
Lipoxygenases and Cardiovascular Diseases
Laguna-Fernández, A., Petri, M. H., Thul, S., & Bäck, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27766-0_6 · Cited by 1
Diversity of Inflammatory Cells in Vascular Degenerative Disease
Hilgendorf, I., & Świrski, F. K. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-66224-4_5 · Cited by 1
Capurso, A., Crepaldi, G., & Capurso, C. A. (2018) · Practical issues in geriatrics · doi:10.1007/978-3-319-78084-9_13 · Cited by 1
Can lipid mediators and free fatty acids guide acute coronary syndrome diagnosis and treatment?
Uzun, G., Ünal, A. Y., Başarıcı, İ., Küçük, M., Dönmez, L., Nacıtarhan, C., & Özdem, S. (2023) · Laboratory Medicine · doi:10.1093/labmed/lmad042 · Cited by 1
Regidor, P., Eiblwieser, J., Steeb, T., & Rizo, J. M. (2024) · F1000Research · doi:10.12688/f1000research.153569.1 · Cited by 1
Omega-3 Fatty Acid Metabolism and Regulation of Inflammation
Isobe, Y., & Arita, M. (2015) · Springer eBooks · doi:10.1007/978-4-431-55669-5_11 · Cited by 1
Resolvins in Periodontal Tissue Homeostasis (Emerging Therapies)
Rakian, A., Rakian, R., Alshehri, N., & Dyke, T. E. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-42990-4_3 · Cited by 1
Wei, C. (2010) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Atherosclerosis in Experimental Animal Models
Merched, A. J., & Chan, L. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.035 · Cited by 1
Self-citationEicosanoides como novos alvos terapêuticos no tratamento de glioblastoma humano.
Souza, F. D. C. (2018) · doi:10.11606/t.42.2018.tde-12032018-095955 · Cited by 1
Valenzuela, N. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.18.449043 · Cited by 1
Exhaled 15-HETE and thromboxin-B2 are associated with the therapeutic outcome in childhood asthmaPreprint
Chen, L., Tseng, H., Kuo, M., Chiu, C., Liao, S., Su, K., Tsai, M., Hua, M. C., Lai, S., Yao, T., et al. (2021) · doi:10.22541/au.161727578.88968481/v1 · Cited by 1
Regidor, P., Eiblwieser, J., Steeb, T., & Rizo, J. M. (2023) · Preprints.org · doi:10.20944/preprints202304.0212.v1 · Cited by 1
Eicosanoides como novos alvos terapêuticos no tratamento de glioblastoma humano.
Souza, F. D. C. (2017) · doi:10.11606/t.42.2017.tde-12032018-095955 · Cited by 1
Duda, M. K. (2012) · Postępy Biochemii
Efeitos citotóxicos de resolvinas da série D em glioma murino
Corrêa, L. T. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Adipokines, Inflammation, and Atherosclerosis
Stulnig, T. M., & Zeyda, M. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_14
POLYCHLORINATED BIPHENYL-INDUCED ENDOTHELIAL CELL DYSFUNCTION AND ITS MODULATION BY DIETARY LIPIDS
Májková, Z. (2010) · UKnowledge (University of Kentucky)
Essential Fatty Acid Metabolism in Metabolic Syndrome and Neurological Disorders
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_3
n-3 polyunsaturated fatty acids to heal the broken heart
Grenon, S. M., & Conte, M. S. (2013) · Clinical Lipidology · doi:10.2217/clp.13.58
Long Chain Polyunsaturated Fatty Acids: Immunomodulators in Disease
Desseyn, J., & Gottrand, F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-061-8_9
Acute Inflammation: A Protective Host Response that May Turn into Harm
Recchiuti, A. (2014)
The role of FPR2/ALX in the vascular wall
Petri, M. H. (2015) · Figshare
ROLE OF 12/15 LIPOXYGENASE EXPRESSION IN LIPID METABOLISM, ATHEROSCLEROSIS AND INSULIN RESISTANCE
Rong, S. (2010) · WakeSpace Scholarship (Wake Forest University)
Progress in Anti-inflammation Effect of n-3 Fatty Acid Metabolites*
Zhang, J., Zhou, K., & Cai, C. (2011) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00108
depotsof lipid mediators in human adipose tissue
Clària, J., Nguyen, B. T., Madenci, A. L., Ozaki, C. K., & Serhan, C. N. (2016)
Self-citationNovel insights into the pathogenesis of metabolic syndrome-related disease
de Boer, J. F. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Lipid Signals in the Resolution of Inflammation
Arita, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_7
RETRACTED ARTICLE: Biological Mechanisms Relating Periodontitis and Diabetes
Hastürk, H., & Kantarcı, A. (2016) · Current Oral Health Reports · doi:10.1007/s40496-016-0100-4
RetractedJung, T. W., Kim, S., Kim, D., Shin, E., Park, Y. B., & Lee, K. (2018) · Pharmacology · doi:10.1159/000487892
Regidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · doi:10.22541/au.160349173.31366855/v1
Selenoproteins modify oxylipids from linoleic acid in macrophages
Peek, S. A. (2014) · Michigan State University Libraries · doi:10.25335/hntg-9g50
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_10
Register der besprochenen Krankheiten
(1873) · De Gruyter eBooks · doi:10.1515/9783111511689-015
Errata for Design of Latticed Steel Transmission Structures (ASCE 10-97), by ASCE
(2000) · American Society of Civil Engineers eBooks · doi:10.1061/9780784403242.ert
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_15
(2016) · Chemical Science Transactions · doi:10.7598/cst2016.1319
(2006) · Brazilian Journal of Cardiovascular Surgery · doi:10.1590/s1678-97412006000100023
Exhaled 15-HETE and thromboxin-B2 are associated with therapeutic outcome in childhood asthmaPreprint
Chen, L., Tseng, H., Kuo, M., Chiu, C., Liao, S., Su, K., Tsai, M., Hua, M., Lai, S., Yao, T., et al. (2024) · doi:10.22541/au.170665000.06002923/v1
Metadata
- Authors
- Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L.
- Affiliations
- Baylor St. Luke's Medical Center (US)
- Brigham and Women's Hospital (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-06-17
- Volume
- 22
- Issue
- 10
- Pages
- 3595-3606
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2537438
- OpenAlex
- W2074102438
- Cited by
- 414
- References
- 55
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 20 · 2022: 14 · 2021: 23 · 2020: 22 · 2019: 17 · 2018: 36 · 2017: 27 · 2016: 32 · 2015: 31 · 2014: 30 · 2013: 28 · 2012: 22
- FWCI
- 27.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association (0465093Y, 0730172N)
- National Institutes of Health (P50 DE016191, HL‐51586)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- atherosclerosis, inflammation resolution, lipid mediators, 12/15-lipoxygenase, 5-lipoxygenase, lipoxin A4, resolvin D1, protectin D1, macrophages, vascular inflammation, ApoE-deficient mice
- MeSH terms
- Animals, Apolipoproteins E, Arachidonate 12-Lipoxygenase, Arachidonate 15-Lipoxygenase, Docosahexaenoic Acids, Endothelium, Vascular, Humans, Interleukins, Macrophages, Vasculitis, Mice, Knockout, Lipoxins, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review